Deception for Drugs: Self-Reported “Doctor Shopping” Among Young Adults

References

1. 1.↵
   1. Johnston LD,
   2. O'Malley PM,
   3. Bachman JG,
   4. Schulenberg JE

   . Monitoring the Future national survey results on drug use, 1975–2012. Volume 1: secondary school students. Ann Arbor: Institute for Social Research, The University of Michigan; 2013.
2. 2.↵
   Results from the 2011 National Survey on Drug Use and Health: summary of national findings, NSDUH Series H-44, HHS Publication No. 12–4713. Rockville, MD: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality; 2012.
3. 3.↵
   The DAWN report: highlights of the 2010 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. Rockville, MD: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality; 2012.
4. 4.↵
   1. Inciardi JA,
   2. Surratt HL,
   3. Kurtz SP,
   4. Cicero TJ

   . Mechanisms of prescription drug diversion among drug-involved club-and street-based populations. Pain Med 2007;8:171–83.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Kaye S,
   2. Darke S

   . The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care? Addiction 2012;107:467–77.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Fountain J,
   2. Strang J,
   3. Gossop M,
   4. Farrel M,
   5. Griffiths P

   . Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London. Addiction 2000;95:393–406.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Wilens TE,
   2. Adler LA,
   3. Adams J,
   4. et al

   . Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 2008;47:21–31.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Singh N,
   2. Fishman S,
   3. Rich B,
   4. Orlowski A

   . Prescription opioid forgery: reporting to law enforcement and protection of medical information. Pain Med 2013;14:792–8.

   OpenUrlPubMed
9. 9.↵
   1. Simoni-Wastila L,
   2. Tompkins C

   . Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential. Subst Use Misuse 2001;36:1275–96.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Karberg J

    . Progress in the challenge to regulate online pharmacies. J Law Health 2010;23:113.

    OpenUrl
11. 11.↵
    1. Hurwitz W

    . The challenge of prescription drug misuse: a review and commentary. Pain Med 2005;6:152–61.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Rigg KK,
    2. March SJ,
    3. Inciardi JA

    . Prescription drug abuse & diversion: role of the pain clinic. J Drug Issues 2010;40:681–702.

    OpenUrlPubMed
13. 13.↵
    1. Gugelmann H,
    2. Perrone J,
    3. Nelson L

    . Windmills and pill mills: can PDMPs tilt the prescription drug epidemic? J Med Toxicol 2012;8:378–86.

    OpenUrlPubMed
14. 14.↵
    1. Inciardi J,
    2. Surratt HL,
    3. Kurtz SP,
    4. Burke JJ

    . The diversion of prescription drugs by health care workers in Cincinnati, Ohio. Subst Use Misuse 2006;41:255–64.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Wang J,
    2. Christo PJ

    . The influence of prescription monitoring programs on chronic pain management. Pain Physician 2009;12:507–15.

    OpenUrlPubMedWeb of Science
16. 16.↵
    1. Wilens TE,
    2. Gignac M,
    3. Swezey A,
    4. Monuteaux MC,
    5. Biederman J

    . Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry 2006;45:408–14.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Grover CA,
    2. Close RJ,
    3. Wiele ED,
    4. Villarreal K,
    5. Goldman LM

    . Quantifying drug-seeking behavior: a case control study. J Emerg Med 2012;42:15–21.

    OpenUrlPubMed
18. 18.↵
    1. Cepeda MS,
    2. Fife D,
    3. Chow W,
    4. Mastrogiovanni G,
    5. Henderson SC

    . Opioid shopping behavior: how often, how soon, which drugs, and what payment method. J Clin Pharmacol 2013;53:112–27.

    OpenUrlPubMed
19. 19.↵
    1. Grover CA,
    2. Elder JW,
    3. Close RJ,
    4. Curry SM

    . How frequently are “classic” drug-seeking behaviors used by drug-seeking patients in the emergency department? West J Emerg Med 2012;13:416–21.

    OpenUrlPubMed
20. 20.↵
    1. Maxfield MG,
    2. Weiler BL,
    3. Widom CS

    . Comparing self-reports and official records of arrests. J Quant Criminol 2000;16:87–110.

    OpenUrl
21. 21.↵
    1. Thornberry TP,
    2. Krohn MD

    . The self-report method for measuring delinquency and crime. Crim Justice 2000;4:33–83.

    OpenUrl
22. 22.↵
    1. O'malley PM,
    2. Bachman JG,
    3. Johnston D

    . Reliability and consistency in self-reports of drug use. Subst Use Misuse 1983;18:805–24.

    OpenUrl
23. 23.↵
    1. Krohn MD,
    2. Thornberry TP,
    3. Gibson CL,
    4. Baldwin JM

    . The development and impact of self-report measures of crime and delinquency. J Quant Criminol 2010;26:509–25.

    OpenUrl
24. 24.↵
    1. Hindelang MJ,
    2. Hirschi T,
    3. Weis JG

    . Measuring delinquency. Beverly Hills, CA: Sage Publications; 1981.
25. 25.↵
    1. Hindelang MJ,
    2. Hirschi T,
    3. Weis JG

    . Correlates of delinquency: the illusion of discrepancy between self-report and official measures. Am Sociol Rev 1979;44:995–1014.

    OpenUrlCrossRefWeb of Science
26. 26.↵
    1. Martin SS,
    2. Enev T,
    3. Harrington D

    . Comparing drug testing and self-report of drug use among youths and young adults in the general population. Washington, DC: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2007.
27. 27.↵
    1. Decker SE,
    2. Frankforter T,
    3. Babuscio T,
    4. Nich C,
    5. Ball SA,
    6. Carroll KM

    . Assessment concordance and predictive validity of self-report and biological assay of cocaine use in treatment trials. Am J Addict 2014 March 15. [Epub ahead of print]
28. 28.↵
    1. Maisto SA,
    2. McKay JR,
    3. Connors GJ

    . Self-report issues in substance abuse: State of the art and future directions. J Behav Assess 1990;12:117–34.

    OpenUrl
29. 29.↵
    1. Sherman MF,
    2. Bigelow GE

    . Validity of patients' self-reported drug use as a function of treatment status. Drug Alcohol Depend 1992;30:1–11.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Barnea Z,
    2. Rahav G,
    3. Teichman M

    . The reliability and consistency of self-reports on substance use in a longitudinal study. Br J Addict 1987;82:891–8.

    OpenUrlCrossRefPubMedWeb of Science
31. 31.↵
    1. Stein LAR,
    2. Colby DM,
    3. O'Leary TA,
    4. et al

    . Response distortion in adolescents who smoke: a pilot study. J Drug Educ 2002;32:271–86.

    OpenUrlCrossRefPubMedWeb of Science
32. 32.↵
    1. Friedman LS,
    2. Johnson B,
    3. Brett AS

    . Evaluation of substance-abusing adolescents by primary care physicians. J Adolesc Health Care 1990;11:227–30.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. King G,
    2. Zeng L

    . Logistic regression in rare events data. Cambridge, MA: Department of Government, Harvard University; 1999.
34. 34.↵
    1. King G,
    2. Zeng L

    . Logistic regression in rare events data. Polit Anal 2009;9:137–63.

    OpenUrl
35. 35.↵
    1. Miller BL,
    2. Boman JH,
    3. Stogner J

    . Examining the measurement of novel drug perceptions: salvia divinorum, gender, and peer substance use. Subst Use Misuse 2013;48:65–72.

    OpenUrlPubMed
36. 36.↵
    1. King G,
    2. Lowe W

    . An automated information extraction tool for international conflict data with performance as good as human coders: a rare events evaluation design. Int Organ 2003;57:617–42.

    OpenUrl
37. 37.↵
    1. Cerdá M,
    2. Wall M,
    3. Keyes KM,
    4. Galea S,
    5. Hasin D

    . Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend 2012;120:22–7.

    OpenUrlPubMed
38. 38.↵
    1. Berridge V

    . Demons: our changing attitudes to alcohol, tobacco, and drugs. Oxford: Oxford University Press; 2013.
39. 39.↵
    1. Cicero TJ,
    2. Inciardi JA,
    3. Muñoz A

    . Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002–2004. J Pain 2005;6:662–72.

    OpenUrlCrossRefPubMedWeb of Science
40. 40.↵
    1. Havens JR,
    2. Oser CB,
    3. Leukefeld CG,
    4. et al

    . Differences in prevalence of prescription opiate misuse among rural and urban probationers. Am J Drug Alcohol Abuse 2007;33:309–17.

    OpenUrlCrossRefPubMedWeb of Science
41. 41.↵
    1. Lankenau SE,
    2. Sanders B,
    3. Bloom JJ,
    4. et al

    . First injection of ketamine among young injection drug users (IDUs) in three US cities. Drug Alcohol Depend 2007;87:183–93.

    OpenUrlCrossRefPubMedWeb of Science
42. 42.↵
    1. Kroutil LA,
    2. Van Brunt DL,
    3. Herman-Stahl MA,
    4. Heller DC,
    5. Bray RM,
    6. Penne MA

    . Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend 2006;84:135–43.

    OpenUrlCrossRefPubMedWeb of Science
43. 43.↵
    1. Rice JB,
    2. White AG,
    3. Birnbaum HG,
    4. Schiller M,
    5. Brown DA,
    6. Roland CL

    . A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med 2012;13:1162–73.

    OpenUrlPubMed
44. 44.↵
    1. Weisburd D,
    2. Piquero AR

    . How well do criminologists explain crime? Statistical modeling in published studies. Crime Justice 2008;37:453–502.

    OpenUrl
45. 45.↵
    1. Bali V,
    2. Raisch DW,
    3. Moffett ML,
    4. Khan N

    . Determinants of nonmedical use, abuse or dependence on prescription drugs, and use of substance abuse treatment. Res Social Adm Pharm 2013;9:276–87.

    OpenUrlPubMed